Clinical trial No longer in our active list Phase1; Phase2 Interventional Ages 45 and up

Investigating balance issues in Parkinson's disease related to inner ear changes

Official title: Vestibulopathy, Imbalance and Gait Disturbances in Parkinson Disease

Run by VA Office of Research and Development · NCT04768647 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing how changes in the inner ear might affect balance problems in people with Parkinson's disease to see if a new treatment can help them feel more stable.

Quick facts

PhasePhase1; Phase2
Study typeInterventional
Ages45 Years and up
SexAll
Enrollment64 (estimated)
SponsorVA Office of Research and Development
Federal
Drugs / interventionsradiation
Locations2 sites (Ann Arbor, Michigan and 1 other locations)
Trial IDNCT04768647 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals diagnosed with Parkinson's disease for more than five years, aged 45 or older, who can ambulate independently.

Probably not a fit

Patients with acute vestibular dysfunction or atypical parkinsonism disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to explore the relationship between vestibular changes and balance problems in individuals with Parkinson's disease. It focuses on understanding how chronic vestibulopathy may contribute to postural instability and gait difficulties, which are often resistant to traditional dopamine treatments. The research will involve dedicated assessment methods to confirm preliminary findings and evaluate the potential benefits of vestibular stimulation as a therapeutic approach. By addressing this knowledge gap, the study seeks to improve the management of balance issues in Parkinson's patients.

Why it matters

Potential benefit: If successful, this study could lead to new treatment options for improving balance and reducing falls in patients with Parkinson's disease.

How similar studies have gone: Preliminary data suggests that vestibulopathy may play a significant role in balance issues for Parkinson's patients, but this specific approach is still being validated.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* PD based on the United Kingdom Parkinson's Disease Society Brain Bank Diagnostic Research Criteria (n=64, gross recruitment)
* M/F
* age 45 years or older
* duration of disease \> 5 years and/or Hoehn \& Yahr stages 1.5-4 able to ambulate independently and no evidence of dementia.

Exclusion Criteria:

* History of Meniere disease or recent onset of acute vestibular dysfunction, such as otolith disorders (BBPV etc).
* Other disorders which may resemble PD, such as progressive supranuclear palsy (PSP), vascular dementia, normal pressure hydrocephalus, multiple system atrophy (MSA), corticobasal ganglionic degeneration, or toxic causes of parkinsonism. Prototypical cases have distinctive clinical profiles, like early and severe dysautonomia (MSA) or appendicular apraxia, which may differentiate them from idiopathic PD and PSP. The use of the UKPDSBRC clinical diagnostic criteria for PD will mitigate the inclusion of subjects with atypical parkinsonism.
* Evidence of a stroke or mass lesion on structural brain imaging (MRI).
* Participants in whom MRI is contraindicated including, but not limited to, those with a pacemaker, presence of metallic fragments near the eyes or spinal cord, or cochlear implant.
* Severe claustrophobia precluding MR or PET imaging.
* Subjects limited by participation in research procedures involving ionizing radiation.
* Pregnancy (test within 48 hours of each PET session) or breastfeeding.

Where it's running

  • VA Ann Arbor Healthcare System, Ann Arbor, MI
    Ann Arbor, Michigan, United States
    Recruiting
  • University of Michigan
    Ann Arbor, Michigan, United States
    Not yet recruiting

Study contacts

  • Principal investigator: Nicolaas I Bohnen, MD PhD — VA Ann Arbor Healthcare System, Ann Arbor, MI
  • Study coordinator: Nicolaas I Bohnen, MD PhD
  • Email: nicolaas.bohnen@va.gov
  • Phone: (734) 769-7100

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.